Literature DB >> 20831303

There's a reason they call them dummy variables: a note on the use of structural equation techniques in comparative effectiveness research.

William H Crown1.   

Abstract

Many research designs and statistical methodologies will be used to conduct comparative effectiveness research (CER). In particular, it is almost certainly the case that the demand for real-world evidence will drive increased demand for CER analyses of observational data. Although a great deal of progress has been made in the development and application of statistical methods for the analysis of observational data, the ordinary least squares multiple regression model remains, by far, the most widely applied multivariate analysis tool. This article begins with a brief review of the interpretation of treatment effects captured through the use of dummy variables in multiple regression models. This review makes clear just how limited this typical estimator of treatment effect is. Structural equation and decomposition methods for CER analyses of observational data are then reviewed. Although these methods have not been commonly used for outcomes research, they offer the opportunity to extract significantly more information regarding treatment effects than the standard dummy variable approach. I have attempted to make the point that traditional dummy variable methods in regression models provide an extremely limited estimate of treatment effects. Structural equation models and decomposition methods provide considerably more information about treatment effects - in particular, the ability to identify how outcomes may vary differentially with respect to patient characteristics and other factors for alternative treatment cohorts. Such an understanding is fundamental to deciphering the heterogeneity of treatment response among patient subpopulations. Structural equation and decomposition methods may be further enhanced by incorporating propensity score matching prior to the analysis. On the other hand, researchers should be wary of the potential pitfalls associated with parametric sample selection bias models. Although tests for selection bias and other forms of endogeneity are an excellent research practice, it is entirely possible that attempts to correct for endogeneity may introduce more bias than they remove. Nonparametric methods, such as differences in differences, while making strong assumptions of their own, avoid the need to identify instrumental variables that are correlated with treatment selection but uncorrelated with residuals in the outcome equation.

Entities:  

Mesh:

Year:  2010        PMID: 20831303     DOI: 10.2165/11537750-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  20 in total

1.  Racial and ethnic differences in access to and use of health care services, 1977 to 1996.

Authors:  R M Weinick; S H Zuvekas; J W Cohen
Journal:  Med Care Res Rev       Date:  2000       Impact factor: 3.929

2.  The contribution of insurance coverage and community resources to reducing racial/ethnic disparities in access to care.

Authors:  J Lee Hargraves; Jack Hadley
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

3.  Estimating marginal and incremental effects on health outcomes using flexible link and variance function models.

Authors:  Anirban Basu; Paul J Rathouz
Journal:  Biostatistics       Date:  2005-01       Impact factor: 5.899

4.  Adjusting for Health Status in Non-Linear Models of Health Care Disparities.

Authors:  Benjamin L Cook; Thomas G McGuire; Ellen Meara; Alan M Zaslavsky
Journal:  Health Serv Outcomes Res Methodol       Date:  2009-03-01

5.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

6.  The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization.

Authors:  W H Crown; R L Obenchain; L Englehart; T Lair; D P Buesching; T Croghan
Journal:  Stat Med       Date:  1998-09-15       Impact factor: 2.373

Review 7.  Instrumental variable methods in comparative safety and effectiveness research.

Authors:  M Alan Brookhart; Jeremy A Rassen; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

8.  The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

9.  The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

10.  Antidepressant selection and use and healthcare expenditures. An empirical approach.

Authors:  W H Crown; T R Hylan; L Meneades
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

View more
  5 in total

1.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Comparison of Pharmaceutical Calculations Learning Outcomes Achieved Within a Traditional Lecture or Flipped Classroom Andragogy.

Authors:  H Glenn Anderson; Lisa Frazier; Stephanie L Anderson; Robert Stanton; Chris Gillette; Kim Broedel-Zaugg; Kevin Yingling
Journal:  Am J Pharm Educ       Date:  2017-05       Impact factor: 2.047

3.  Looking to the future: incorporating genomic information into disparities research to reduce measurement error and selection bias.

Authors:  Alexandra E Shields; William H Crown
Journal:  Health Serv Res       Date:  2012-04-19       Impact factor: 3.402

Review 4.  From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer.

Authors:  Richard J Willke; Zhiyuan Zheng; Prasun Subedi; Rikard Althin; C Daniel Mullins
Journal:  BMC Med Res Methodol       Date:  2012-12-13       Impact factor: 4.615

5.  Comparative effectiveness research on patients with acute ischemic stroke using Markov decision processes.

Authors:  Darong Wu; Yefeng Cai; Jianxiong Cai; Qiuli Liu; Yuanqi Zhao; Jingheng Cai; Min Zhao; Yonghui Huang; Liuer Ye; Yubo Lu; Xianping Guo
Journal:  BMC Med Res Methodol       Date:  2012-03-09       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.